These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34866136)

  • 81. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
    Dow E; Buchanan DD; Winship IM
    Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
    Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
    JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.
    Walsh MD; Buchanan DD; Pearson SA; Clendenning M; Jenkins MA; Win AK; Walters RJ; Spring KJ; Nagler B; Pavluk E; Arnold ST; Goldblatt J; George J; Suthers GK; Phillips K; Hopper JL; Jass JR; Baron JA; Ahnen DJ; Thibodeau SN; Lindor N; Parry S; Walker NI; Rosty C; Young JP
    Mod Pathol; 2012 May; 25(5):722-30. PubMed ID: 22322191
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
    Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
    Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
    Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
    Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Penetrance estimates for
    Evans DG; Woodward E; Harkness EF; Howell A; Plaskocinska I; Maher ER; Tischkowitz MD; Lalloo F
    J Med Genet; 2018 Jul; 55(7):442-448. PubMed ID: 29483236
    [TBL] [Abstract][Full Text] [Related]  

  • 88. From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.
    Lepore Signorile M; Disciglio V; Di Carlo G; Pisani A; Simone C; Ingravallo G
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201893
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM
    Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A
    Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Inherited Cancer Susceptibility Gene Sequence Variations Among Patients With Appendix Cancer.
    Holowatyj AN; Washington MK; Tavtigian SV; Eng C; Horton C
    JAMA Oncol; 2022 Nov; 9(1):95-101. PubMed ID: 36368039
    [TBL] [Abstract][Full Text] [Related]  

  • 91. DNA damage response in breast cancer and its significant role in guiding novel precise therapies.
    Li J; Jia Z; Dong L; Cao H; Huang Y; Xu H; Xie Z; Jiang Y; Wang X; Liu J
    Biomark Res; 2024 Sep; 12(1):111. PubMed ID: 39334297
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Family communication of cancer genetic test results in an ethnically diverse population: a qualitative exploration of more than 200 patients.
    Hodan R; Picus M; Stanclift C; Ormond KE; Pichardo JM; Kurian AW; Ricker C; Idos GE
    J Community Genet; 2024 Aug; 15(4):363-374. PubMed ID: 38814439
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pathogenic variant detection rate varies considerably in male breast cancer families and sporadic cases: minimal additional contribution beyond
    Evans DG; Burghel GJ; Howell SJ; Pugh S; Forde C; Howell A; Lalloo F; Woodward ER
    J Med Genet; 2024 Aug; 61(9):853-855. PubMed ID: 38609177
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
    Evans DG; Green K; Burghel GJ; Forde C; Lalloo F; Schlecht H; Woodward ER
    Fam Cancer; 2024 Jun; 23(2):187-195. PubMed ID: 38478259
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Biomarkers and experimental models for cancer immunology investigation.
    Xu H; Jia Z; Liu F; Li J; Huang Y; Jiang Y; Pu P; Shang T; Tang P; Zhou Y; Yang Y; Su J; Liu J
    MedComm (2020); 2023 Dec; 4(6):e437. PubMed ID: 38045830
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
    AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
    Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    Flaum N; Crosbie EJ; Woodward ER; Lalloo F; Morgan R; Ryan N; Evans DG
    J Med Genet; 2023 Jun; 60(6):576-577. PubMed ID: 36894311
    [No Abstract]   [Full Text] [Related]  

  • 99. 2022: the year that was in the European Journal of Human Genetics.
    McNeill A
    Eur J Hum Genet; 2023 Feb; 31(2):131-133. PubMed ID: 36750730
    [No Abstract]   [Full Text] [Related]  

  • 100. Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records.
    Loong L; Huntley C; McRonald F; Santaniello F; Pethick J; Torr B; Allen S; Tulloch O; Goel S; Shand B; Rahman T; Luchtenborg M; Garrett A; Barber R; Bedenham T; Bourn D; Bradshaw K; Brooks C; Bruty J; Burghel GJ; Butler S; Buxton C; Callaway A; Callaway J; Drummond J; Durkie M; Field J; Jenkins L; McVeigh TP; Mountford R; Nyanhete R; Petrides E; Robinson R; Scott T; Stinton V; Tellez J; Wallace AJ; Yarram-Smith L; Sahan K; Hallowell N; Eccles DM; Pharoah P; Tischkowitz M; Antoniou AC; Evans DG; Lalloo F; Norbury G; Morris E; Burn J; Hardy S; Turnbull C
    J Med Genet; 2023 Jul; 60(7):669-678. PubMed ID: 36572524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.